2 ASX mining shares tipped to grow 45% or more in the next 12 months

These producers look like they're going cheap at the moment.

Investing in Australian mining stocks can be lucrative, but which ones to buy?

This week I've sifted through the reports released by UBS and come up with two companies their analyst team believes are deeply undervalued.

Let's see who they like.

A man in a hard hat gives a thumbs up as he holds a clipboard in one hand against a blue sky background.

Image source: Getty Images

Lynas Rare Earths Ltd (ASX: LYC)

Lynas shares are up a healthy 51% over the past 12 months but have experienced some weakness over the past three months.

The stock was sold off recently after reporting its fourth quarter results, despite booking $288.9 million in quarterly revenue, significantly up on the $170.2 million it booked for the same quarter last year.

Lynas Chief Executive Officer Pol Le Roux said the quarter, "saw the continued focus on the efficient operation of our $1.5 billion investment in new capacity which was completed as part of the Lynas 2025 growth initiative''.

UBS said the company's production of 1857 tonnes of neodymium fell short of their expected 2200 tonnes, "with the operational weakness impacting sales volumes and in turn revenue''.

UBS added:

Positively, the market continues to improve and combined with LYC's leading position in ex-China rare earths production and focus on heavies will play in LYC's favour into the medium-term.

UBS said Lynas management expressed confidence that their production issues were temporary, "highlighting a combination of work through the flow sheet that will help improve operational performance going forward".

UBS lowered their price target for Lynas shares from $23.45 to $22.75; however, this is still well above the current share price of $15.25. The price target would be a 49% return if achieved.

Westgold Resources Ltd (ASX: WGX)

Westgold's share price performance recently mirrors that of Lynas, with a strong performance over a 12-month period, up 67.4%, but a weaker performance over the past three months also.

But in contrast, Westgold which also reported its quarterly results in past days, beat its guidance, producing 387,354 ounces of gold compared to guidance of 345,000-385,000 ounces.

Westgold Managing Director Wayne Bramwell said it was a defining year for the company.

He added:

Over the past two years, we have simplified our portfolio, focused on our highest return assets and prudently allocated capital on key projects and infrastructure that enables future growth. In FY26, this strategy delivered record annual production of 387,354oz, above our guidance range, achieved our cost guidance, and placed Westgold in the strongest treasury position in its history. Improving operational delivery generated an underlying cash build of $233M for the quarter, with Westgold closing FY26 with $939M in cash, bullion and liquid investments. We remain debt free, unhedged and with the financial strength to fund both organic growth, and ongoing return of capital to our shareholders.

UBS ran the ruler over the results, and lowered its price target on the company due to expected lower gold grades at one of its operations.

UBS now has a price target of $7.75 on Westgold shares, compared to $4.80 currently. This would be a 61.4% return if achieved.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Lynas Rare Earths Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »